Akcea Therapeutics, Inc. Accumulated Other Comprehensive Income
Akcea Therapeutics, Inc. had Accumulated Other Comprehensive Income of $1.48 million as of 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2020-08-05
- 2020-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.48M.
- 2020-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $391.00K.
- 2019-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $5.00K.
- 2019-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$63.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2020-06-30 | $1.48M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $391.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $5.00K 10-Q · filed 2020-08-05 |
| 2019-09-30 | -$63.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$110.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$27.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$324.00K 10-K · filed 2020-03-02 |
| 2018-09-30 | -$289.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | -$297.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$468.00K 10-Q · filed 2018-05-07 |
| 2017-12-31 | -$451.00K 10-K · filed 2019-03-01 |
| 2017-09-30 | -$222.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$84.00K 10-Q · filed 2017-08-09 |
| 2016-12-31 | -$21.00K 8-K · filed 2018-09-18 |